Should You Buy the Dip in Healthcare Trust of America?

NYSE: HTA | Healthcare Trust of America, Inc.  News, Ratings, and Charts

HTA – Shares of medical REIT Healthcare Trust of America (HTA) slumped in price after the company’s reverse merger with Healthcare Realty Trust. And as the company’s profit margins take a hit due to increased operating costs derived from several macroeconomic headwinds, is HTA an ideal investment bet now? Read more to learn our view.

Healthcare Trust of America, Inc. (HTA) is the largest dedicated owner and operator of medical office buildings in the U.S. As of September 30, 2021, HTA’s assets comprised approximately 25.80 million square feet of gross leasable area (GLA) and $7.70 billion worth investments in medical office buildings. The Scottsdale, Ariz.-based company has an ISS Governance QualityScore of 1, indicating low governance risk.

On February 18, HTA announced plans to merge with Healthcare Realty Trust Incorporated. Following the merger, HTA shareholders are set to receive a total implied value of $35.08 per share, including a special dividend of $4.82 per share. The newly merged company has a pro forma equity market cap of $11.60 billion and an EV of $17.60 billion.

However, shares of HTA declined 1.6% in price following the announcement of the merger. This is because HTA shareholders are slated to receive only the special dividend payout, because the business combination is structured as a reverse merger, with HTA buying Healthcare Realty Trust’s shares. Also, the stock has declined 9.7% in price year-to-date.

Here is what could shape HTA’s performance in the near term:

Mixed Financials

HTA’s revenues have increased 4.6% year-over-year to $195.70 million in its fiscal fourth quarter, ended Dec. 31, 2021. This can be attributed to a 3.6% rise in rental income and a 2211.1% improvement in interest and other operating income. The company’s quarterly dividend payout increased by $0.05 to $0.325 in the last quarter.

However, the company’s net income has declined 41.7% from the same period last year to $16.61 million due to a 10.4% rise in total expenses. Its FFO came in at $0.07, down 46.2% from the prior-year quarter. Furthermore, HTA’s net operating cash flow declined marginally year-over-year to $385.62 million.

Stable Growth

Analysts expect HTA’s revenues to rise 2.8% in its fiscal year 2022 first quarter (ending March), 5.2% in the second quarter (ending June 2022), and 5% in the current year. The consensus FFO estimates indicate a 3.2% year-over-year improvement in the current quarter, a 3.9% rise in the next quarter, and a 3.4% increase in fiscal 2022. In addition, the Street expects the company’s revenue and FFO to increase 6.9% and 3.7%, respectively, next year.

Stretched Valuation

In terms of forward P/AFFO, HTA is currently trading at 20.41x, which is 7.4% higher than the 19x industry average. Its 16.91 forward P/FFO multiple is slightly higher than the 2.30 industry average.

In addition, the stock’s trailing-12-month Price/Rental revenue and Price/Cash Flow ratios of 9.18 and 18.18, respectively, compare with the 8.62 and 17.27 industry averages. Furthermore, HTA’s 22.84 trailing-12-month EV/EBITDA multiple is 3.7% higher than the 22.04 industry average.

Consensus Rating and Price Target Indicate Potential Upside

Among the six Wall Street analysts that rated HTA, one rated it Buy while four rated it Hold. The 12-month median price target of $34.20 indicates an 11.7% potential upside from yesterday’s closing price of $30.61. The price targets range from a low of $30.00 to a high of $38.00.

POWR Ratings Reflect Uncertainty

HTA has an overall C rating, which translates to Neutral in our proprietary POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

HTA has a B grade for Growth but a D for Value and Quality. The company’s revenues have increased at a 3.3% CAGR over the past three years and at a 10.8% CAGR over the past five years, which is in sync with its Growth grade. However, the stock’s premium valuation justifies the Value grade. In addition, HTA’s 3.05% trailing-12-month ROE is 40.5% lower than the 5.12% industry average, and in sync with the Quality grade.

Among the 17 stocks in the D-rated REITs – Healthcare industry, HTA is ranked #13.

Beyond what I have stated above, view HTA ratings for Sentiment, Stability, and Momentum here.

Bottom Line

HTA’s recent merger is expected to significantly boost the company’s domestic market presence. However, with declining profit margins and operating cash flows, the fund outflow resulting from this merger could harm the company’s working capital fund availability in the near term. Furthermore, we think that as the broader market weakness continues, investors should wait until the REIT giant’s cash flows stabilize before investing in the stock.

How Does Healthcare Trust of America (HTA) Stack Up Against its Peers?

While HTA has a C rating in our proprietary rating system, one might want to consider looking at its industry peers, Universal Health Realty Income Trust (UHT) and NorthWest Healthcare Properties Real Estate Investment Trust (NWHUF), which have a B (Buy) rating.

HTA shares were trading at $30.57 per share on Friday morning, down $0.04 (-0.13%). Year-to-date, HTA has declined -7.55%, versus a -9.91% rise in the benchmark S&P 500 index during the same period.

About the Author: Aditi Ganguly

Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do’s and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
HTAGet RatingGet RatingGet Rating
UHTGet RatingGet RatingGet Rating
NWHUFGet RatingGet RatingGet Rating

Most Popular Stories on

3 AI Stocks to Buy Now

AI regulation is a foregone conclusion, it's just left to be determined who in government will formulate the rules and enforce them. Elon Musk thinks a whole new agency will be needed to enforce the massive amount of regulation coming down the road. These three companies, Red Violet (RDVT), Akamai (AKAM) and Cisco (CSCO), are at the forefront of companies implementing those regulations, and should see a pretty penny in profits for their work.

Stock Alert: Just Another BUY THE DIP Opportunity

Traders threw a tantrum after the Fed shared details on their rate hike plans. This has the S&P 500 (SPY) hitting the lowest level in quite a while. Gladly, things are not as dire as they seem. That is why Steve Reitmeister shares his latest insights to explain why a bull market is still in place...and how to target the best stocks and ETFs for the days ahead. Read on for the full story below...

My Favorite Energy Stock Under $10

Oil is back in the headlines as it has rocketed higher on a combination of factors over the past two months. This means oil stocks should definitely be back on your radar. And this under $10 oil stock has popped up on the POWR Ratings radar, Battalion Oil (BATL).

Coca-Cola (KO) and 2 More Beverage Stocks – Buy or Sell?

The beverage industry exhibits a bright outlook due to evolving consumer preferences amid rising health consciousness. Therefore, let us analyze whether leading beverage stocks Coca-Cola (KO), National Beverage (FIZZ), and Celsius Holdings (CELH) are Buy, Hold, or Sell now. Read more...

100 Best Stocks for October

Our computer models are dialed into the 100 best stocks for October 2023. What makes them “the best stocks”? Years of hard work to find the precise factors that lead to market beating stocks (SPY). Like our coveted strategy with an average annual return of +57.15%. And yes, it even produced impressive profits during the 2022 bear market. Now is the time to discover the winning stocks it is picking for the weeks and months ahead. Get full details below...

Read More Stories

More Healthcare Trust of America, Inc. (HTA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All HTA News